PMID- 31100378 OWN - NLM STAT- MEDLINE DCOM- 20200210 LR - 20200210 IS - 1879-3177 (Electronic) IS - 0887-2333 (Linking) VI - 60 DP - 2019 Oct TI - Assessment of a defined approach based on a stacking prediction model to identify skin sensitization hazard. PG - 134-143 LID - S0887-2333(18)30758-6 [pii] LID - 10.1016/j.tiv.2019.05.008 [doi] AB - Skin sensitization is an important toxicological endpoint in the safety assessment of chemicals and cosmetic ingredients. Driven by ethical considerations and European Union (EU) legislation, its assessment has progressed from the reliance on traditional animal models to the use of non-animal test methods. It is generally accepted that the assessment of skin sensitization requires the integration of various non-animal test methods in defined approaches (DAs), to cover the mechanistic key events of the adverse outcomes pathway (AOP) (OECD, 2014). Several case studies for DAs predicting skin sensitization hazard or potency have been submitted to the OECD, including a stacking meta-model developed by L'Oreal Research & Innovation (OECD, 2017b; Del Bufalo et al., 2018; Nocairi et al., 2016). The present study evaluated the predictive performance of the defined approach integrating a stacking meta-model incorporating in silico, in chemico and in vitro assays, using the Cosmetics Europe (CE) skin sensitization database. Based on the optimized prediction cut-offs, the defined approach provided a hazard prediction for 97 chemicals with a sensitivity of 91%, a specificity of 76% and accuracy of 86% (kappa of 0.67) against human skin sensitization hazard data and a sensitivity of 85%, specificity of 91% and accuracy of 87% (kappa of 0.67) against Local Lymph Node Assay (LLNA) hazard data. A comparison of the in vivo LLNA with human hazard data for the same 97 chemicals showed a sensitivity of 92%, specificity of 51% and accuracy of 78% (kappa of 0.48). Thus, the defined approach showed a higher degree of concordance, as compared to the LLNA for predicting human skin sensitization hazard. Moreover, a comparison with the six DAs selected for evaluation of their predictivity in the study by Kleinstreuer et al. (2018) showed a similar high accuracy of 86% for 97 overlapping chemicals. The next step will be an independent evaluation of the DA for its integration in the performances based test guidelines (PBTG) for skin sensitization. CI - Copyright (c) 2019 Elsevier Ltd. All rights reserved. FAU - Tourneix, Fleur AU - Tourneix F AD - L'Oreal Research & Innovation, Aulnay-sous-Bois, France. Electronic address: fleur.tourneix@rd.loreal.com. FAU - Alepee, Nathalie AU - Alepee N AD - L'Oreal Research & Innovation, Aulnay-sous-Bois, France. FAU - Detroyer, Ann AU - Detroyer A AD - L'Oreal Research & Innovation, Aulnay-sous-Bois, France. FAU - Eilstein, Joan AU - Eilstein J AD - L'Oreal Research & Innovation, Aulnay-sous-Bois, France. FAU - Martinozzi Teissier, Silvia AU - Martinozzi Teissier S AD - L'Oreal Research & Innovation, Aulnay-sous-Bois, France. FAU - Nardelli, Laurent AU - Nardelli L AD - L'Oreal Research & Innovation, Aulnay-sous-Bois, France. FAU - Nocairi, Hicham AU - Nocairi H AD - L'Oreal Research & Innovation, Aulnay-sous-Bois, France. FAU - Pauloin, Thierry AU - Pauloin T AD - L'Oreal Research & Innovation, Aulnay-sous-Bois, France. FAU - Piroird, Cecile AU - Piroird C AD - L'Oreal Research & Innovation, Aulnay-sous-Bois, France. FAU - Del Bufalo, Aurelia AU - Del Bufalo A AD - L'Oreal Research & Innovation, Aulnay-sous-Bois, France. LA - eng PT - Journal Article DEP - 20190514 PL - England TA - Toxicol In Vitro JT - Toxicology in vitro : an international journal published in association with BIBRA JID - 8712158 RN - 0 (Haptens) SB - IM MH - Animal Testing Alternatives MH - Computer Simulation MH - Databases, Factual MH - Dermatitis, Allergic Contact MH - Haptens/*toxicity MH - Humans MH - *Models, Biological OTO - NOTNLM OT - Defined approach OT - Hazard identification OT - In silico OT - In vitro OT - Risk assessment OT - Skin sensitization EDAT- 2019/05/18 06:00 MHDA- 2020/02/11 06:00 CRDT- 2019/05/18 06:00 PHST- 2018/11/22 00:00 [received] PHST- 2019/05/10 00:00 [revised] PHST- 2019/05/13 00:00 [accepted] PHST- 2019/05/18 06:00 [pubmed] PHST- 2020/02/11 06:00 [medline] PHST- 2019/05/18 06:00 [entrez] AID - S0887-2333(18)30758-6 [pii] AID - 10.1016/j.tiv.2019.05.008 [doi] PST - ppublish SO - Toxicol In Vitro. 2019 Oct;60:134-143. doi: 10.1016/j.tiv.2019.05.008. Epub 2019 May 14.